Write a reviewFor vendors
♡
Home / Investors / Michael Aberman

Michael Aberman

Venture Fund · New York City

About Michael Aberman

Venture capital investor (General Partner) based in New York City, New York. Focus areas include Biotechnology, Pharmaceuticals. Invests at seed, pre-seed stage. Past investments include XenImmune Therapeutics, Inc., Immunai, Antigenics.

Investment focus

Stages
SeedPre-Seed
Sectors
BiotechnologyPharmaceuticals

Portfolio

No portfolio companies recorded yet; Michael Aberman reports 7 investments overall.

Similar investors

Y Combinator

Accelerator · Mountain View · Founded 2005
SeedSeries ASeries BEntertainment & MediaCreator EconomyParentingInformation Technology+88
4441Investments
440Exits

500 Startups

Venture Fund · San Francisco · Founded 2010
SeedSeries ASeries BFinTechHealthcareInformation TechnologyMarketing (MarTech)+72
2802Investments
337Exits

Bossanova Investimentos

Venture Fund · São Paulo, Brazil · Founded 2011
SeedSeries ASeries BInformation TechnologyMarketing (MarTech)SaaSSales Automation+75
1360Investments
101Exits

SV Angel

Venture Fund · San Francisco · Founded 2009
SeedSeries ASeries BEntertainment & MediaCreator EconomyCloudTechDeveloper Tools+69
1344Investments
409Exits

Bessemer Venture Partners

Venture Fund · Redwood City, California · Founded 2011
Pre-SeedSeedSeries ASeries BEntertainment & MediaCreator EconomyEdTechBig Data & Analytics+59
1257Investments
281Exits

Andreessen Horowitz

Venture Fund · Menlo Park · Founded 2009
Pre-SeedSeedSeries ASeries BFinTechSaaSCryptocurrency / BlockchainAdvertising (AdTech)+82
1231Investments
191Exits